Calvin Ke

3.7k total citations · 2 hit papers
33 papers, 573 citations indexed

About

Calvin Ke is a scholar working on Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Calvin Ke has authored 33 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Public Health, Environmental and Occupational Health and 6 papers in Genetics. Recurrent topics in Calvin Ke's work include Diabetes Treatment and Management (10 papers), Diabetes Management and Education (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers). Calvin Ke is often cited by papers focused on Diabetes Treatment and Management (10 papers), Diabetes Management and Education (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers). Calvin Ke collaborates with scholars based in Canada, Hong Kong and China. Calvin Ke's co-authors include Baiju R. Shah, Juliana C.N. Chan, Andrea O. Y. Luk, Prabhat Jha, K.M. Venkat Narayan, Ronald C.W., Eric S. H. Lau, Alice P.S. Kong, Elaine Chow and Wing‐Yee So and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Calvin Ke

28 papers receiving 566 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations

2022 140 citations Calvin Ke, K.M. Venkat Narayan et al. Nature Reviews Endocrinology profile →
Current insights and emerging trends in early-onset type 2 diabetes

2023 86 citations Shivani Misra, Calvin Ke et al. The Lancet Diabetes & Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Calvin Ke Canada	11	364	121	95	86	86	33	573
Weigang Zhao China	13	241 0.7×	54 0.4×	137 1.4×	87 1.0×	83 1.0×	55	547
Thaddäus Tönnies Germany	13	230 0.6×	113 0.9×	94 1.0×	55 0.6×	53 0.6×	35	492
Abdullah M. Alguwaihes Saudi Arabia	12	261 0.7×	57 0.5×	66 0.7×	57 0.7×	49 0.6×	31	612
Alessandra Bertolotto Italy	15	273 0.8×	76 0.6×	56 0.6×	203 2.4×	71 0.8×	36	713
Tina Brenneman United States	2	434 1.2×	88 0.7×	61 0.6×	43 0.5×	110 1.3×	2	600
Ulagamathesan Venkatesan India	12	194 0.5×	68 0.6×	67 0.7×	49 0.6×	38 0.4×	46	399
Michael J. O’Grady United States	10	441 1.2×	140 1.2×	174 1.8×	155 1.8×	54 0.6×	14	775
Virginia Bellido Spain	15	419 1.2×	184 1.5×	46 0.5×	150 1.7×	55 0.6×	48	643
Hubert S. Chou United States	9	325 0.9×	95 0.8×	42 0.4×	117 1.4×	100 1.2×	12	453
Umesh Dashora United Kingdom	11	344 0.9×	108 0.9×	56 0.6×	153 1.8×	77 0.9×	52	547

Countries citing papers authored by Calvin Ke

Since Specialization

Citations

This map shows the geographic impact of Calvin Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calvin Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calvin Ke more than expected).

Fields of papers citing papers by Calvin Ke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Calvin Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calvin Ke. The network helps show where Calvin Ke may publish in the future.

Co-authorship network of co-authors of Calvin Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Calvin Ke. A scholar is included among the top collaborators of Calvin Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calvin Ke. Calvin Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hong, Zhen, et al.. (2025). Early Life Exposure to the Great Chinese Famine and Cardiometabolic Outcomes. JAMA Network Open. 8(11). e2545444–e2545444.

Yang, Aimin, Mai Shi, Hongjiang Wu, et al.. (2025). Trends of lipid-lowering drug utilization, treatment intensity and LDL-C target attainment in adults with diabetes and non-dialysis chronic kidney disease in Hong Kong. The Lancet Regional Health - Western Pacific. 63. 101696–101696.

Ke, Calvin, Sonia S. Anand, Eric E. Smith, et al.. (2025). Covert Vascular Brain Injury and Cognitive Dysfunction Among Chinese Adults Living in Canada and China. Neurology. 104(3). e210246–e210246. 1 indexed citations

Booth, Gillian L., Ghazal S. Fazli, Calvin Ke, et al.. (2024). Rising Prevalence of Gestational Diabetes Mellitus in Ontario: A Population-based Study. Canadian Journal of Diabetes. 48(8). 539–543. 2 indexed citations

Vyas, Manav V., et al.. (2024). Determinants, Prevention, and Incidence of Cardiovascular Disease Among Immigrant and Refugee Populations. Canadian Journal of Cardiology. 40(6). 1077–1087. 5 indexed citations

Kanagalingam, Tharsan, Catherine Yu, & Calvin Ke. (2024). Young-onset type 2 diabetes. Canadian Medical Association Journal. 196(28). E977–E977.

Misra, Shivani, Calvin Ke, Shylaja Srinivasan, et al.. (2023). Current insights and emerging trends in early-onset type 2 diabetes. The Lancet Diabetes & Endocrinology. 11(10). 768–782. 86 indexed citations breakdown →

Ke, Calvin, Thérèse A. Stukel, Deva Thiruchelvam, & Baiju R. Shah. (2023). Ethnic differences in the association between age at diagnosis of diabetes and the risk of cardiovascular complications: a population-based cohort study. Cardiovascular Diabetology. 22(1). 241–241. 1 indexed citations

Ke, Calvin, Anna Chu, Baiju R. Shah, et al.. (2023). Association of prior outpatient diabetes screening with cardiovascular events and mortality among people with incident diabetes: a population-based cohort study. Cardiovascular Diabetology. 22(1). 227–227. 2 indexed citations

10.

Ke, Calvin, K.M. Venkat Narayan, Juliana C.N. Chan, Prabhat Jha, & Baiju R. Shah. (2022). Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations. Nature Reviews Endocrinology. 18(7). 413–432. 140 indexed citations breakdown →

11.

Ke, Calvin, Rajeev Gupta, Baiju R. Shah, et al.. (2021). Association of Hypertension and Diabetes with Ischemic Heart Disease and Stroke Mortality in India: The Million Death Study. Global Heart. 16(1). 69–69. 18 indexed citations

12.

Ke, Calvin, Andrea O. Y. Luk, Juliana C.N. Chan, Xiaolin Wei, & Baiju R. Shah. (2021). Migration and diabetes incidence among Chinese adults in Canada, China, Hong Kong, and Taiwan: An international population-based comparative study from 2000 to 2017. Diabetes Research and Clinical Practice. 180. 109062–109062. 7 indexed citations

13.

Ke, Calvin, Thérèse A. Stukel, Baiju R. Shah, et al.. (2020). Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: A population-based observational study. PLoS Medicine. 17(9). e1003316–e1003316. 39 indexed citations

14.

Luk, Andrea O. Y., Calvin Ke, Eric S. H. Lau, et al.. (2020). Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study. PLoS Medicine. 17(2). e1003052–e1003052. 61 indexed citations

15.

Lowe, Julia, et al.. (2020). Development and Validation of a New Diabetes Risk Score in Guyana. Diabetes Therapy. 11(4). 873–883. 2 indexed citations

16.

Ke, Calvin, Baiju R. Shah, Arlene S. Bierman, et al.. (2019). Impact of Socioeconomic Status on Incidence of End-Stage Renal Disease and Mortality After Dialysis in Adults With Diabetes. Canadian Journal of Diabetes. 43(7). 483–489.e4. 9 indexed citations

17.

Yu, Catherine, et al.. (2019). Beyond pros and cons – developing a patient decision aid to cultivate dialog to build relationships: insights from a qualitative study and decision aid development. BMC Medical Informatics and Decision Making. 19(1). 186–186. 22 indexed citations

18.

Ke, Calvin, Baiju R. Shah, Andrea O. Y. Luk, Erica Di Ruggiero, & Juliana C.N. Chan. (2019). Cardiovascular outcomes trials in type 2 diabetes: Time to include young adults. Diabetes Obesity and Metabolism. 22(1). 3–5. 25 indexed citations

19.

Ke, Calvin, Steve Morgan, Kate Smolina, et al.. (2017). Is cardiovascular risk reduction therapy effective in South Asian, Chinese and other patients with diabetes? A population-based cohort study from Canada. BMJ Open. 7(8). e013808–e013808. 5 indexed citations

20.

Ke, Calvin, Steve Morgan, Kate Smolina, et al.. (2016). Mortality and Cardiovascular Risk of Sulfonylureas in South Asian, Chinese and Other Canadians with Diabetes. Canadian Journal of Diabetes. 41(2). 150–155. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact